Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | DGAT2 | Q96PD7 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | VDR | P11473 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.36 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.35 |
| ▸ | MGAT2 | Q10469 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4530341 | 0.82 | MAOA (0.43) | CYP1A2CYP3A4CYP2C9CYP2B6BACE1 | |
| SCHEMBL3888994 | 0.81 | ESR1 (0.40) | GPR84CYP1A2CYP3A4VDRCYP2C9 | |
| SCHEMBL6926344 | 0.74 | PTGS1 (0.41) | GSTP1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL25818576 | 0.74 | FABP4 (0.42) | GSTP1BACE1HPGDKDM4EALDH1A1 | |
| SCHEMBL10197719 | 0.74 | CRHBP (0.39) | BRD4GPR84DGAT2DHODHMGAT2 | |
| SCHEMBL11971603 | 0.73 | NQO1 (0.46) | GPR84BACE1ALOX5HPGDKDM4E | |
| SCHEMBL11978650 | 0.73 | MCL1 (0.43) | GPR84CYP2C9HPGDKDM4EMEN1 | |
| SCHEMBL3415539 | 0.72 | ALDH1A1 (0.53) | BRD4BACE1ALOX5HPGDKDM4E | |
| SCHEMBL29728323 | 0.72 | ALDH1A1 (0.53) | BRD4BACE1ALOX5HPGDKDM4E | |
| SCHEMBL3689307 | 0.72 | HSD17B1 (0.53) | GSTP1CYP1A2CYP3A4CYP2C9CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1903020-B1 | BIPHENYL DERIVATIVES, ORGANIC ELECTROLUMINESCENT MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO (JP) | 2014-03-19 | — | — | EP | disclosed |
| US-7560604-B2 | Biphenyl derivative, material for organic electroluminescence device, and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-07-14 | — | — | US | disclosed |
| EP-1903020-A1 | BIPHENYL DERIVATIVES, ORGANIC ELECTROLUMINESCENT MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-03-26 | — | — | EP | disclosed |
| US-20070013296-A1 | Biphenyl derivative, material for organic electroluminescence device, and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070013296-A1 | Biphenyl derivative, material for organic electroluminescence device, and organic electroluminescence device using the same | EED, BMI1, EBPL | GSTP1 1085/4885BRD4 167/4885GPR84 3986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.